FDA guidance spells out acceptance criteria for synthetic peptide ANDAs
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaQuality Assurance and ControlRegulatory Intelligence/Policy